Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets
July 18th, 2019
15.4K views
Here, we present a protocol to generate high-quality, large-scale transcriptome data of single cells from isolated human pancreatic islets using a droplet-based microfluidic single-cell RNA sequencing technology.
Overview
This protocol generates high throughput transcription data of individual human islet cells, facilitating the study of cell heterogeneity and gene regulation in disease. The technique is user-friendly and offers a short processing time, making it applicable to islets from various species.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Genomics
Background
- Single-cell RNA sequencing provides insights into cellular diversity.
- Understanding pancreatic islet cell types is crucial for diabetes research.
- High-quality dissociation of cells is essential for accurate results.
- Optimizing protocols for different tissues enhances applicability.
Purpose of Study
- To generate large-scale transcriptome data from human pancreatic islet cells.
- To identify rare cell types and study gene regulation.
- To improve understanding of cellular heterogeneity in islets.
Methods Used
- Droplet-based microfluidic single-cell RNA sequencing technology.
- Isolation of human pancreatic islets.
- Quality control of cell suspension prior to sequencing.
- Optimization of tissue-specific dissociation procedures.
Main Results
- Successful generation of high-quality transcriptome data.
- Identification of diverse cell populations within islets.
- Insights into gene regulation mechanisms in disease contexts.
- Potential for application to other freshly isolated tissues.
Conclusions
- The protocol is effective for studying pancreatic islet cell heterogeneity.
- High-quality dissociation and handling are critical for success.
- Further optimization may enhance its applicability across different tissues.
Frequently Asked Questions
What is the main advantage of this protocol?
It allows for high throughput generation of transcriptome data from individual cells.
Can this method be applied to other tissues?
Yes, it can be adapted for use with other freshly isolated tissues.
What is critical for the success of this protocol?
Preparing high-quality dissociated cells and careful handling of the emulsion are essential.
How does this protocol contribute to diabetes research?
It helps identify rare cell types and understand gene regulation in pancreatic islets.
What technology is used in this protocol?
Droplet-based microfluidic single-cell RNA sequencing technology is utilized.
Is the processing time for this protocol short?
Yes, the protocol is designed to have a fairly short processing time.
Executive Industry Relevance
Single-cell RNA sequencing of human pancreatic islets enables high-resolution mapping of endocrine cell heterogeneity, supporting mechanistic de-risking and target validation in metabolic disease research. This approach delivers quantitative, cell-type-specific transcriptomic data, informing early discovery and translational biomarker strategies. The protocol's scalability and rigorous quality control facilitate robust portfolio decisions in diabetes and related therapeutic areas.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of gene expression at single-cell resolution for functional target validation.
- Supports identification of rare endocrine cell types and subpopulations relevant to disease mechanisms.
- Provides mechanistic de-risking by clarifying cellular heterogeneity and gene regulation pathways.
- Facilitates predictive confidence in target selection and prioritization.
Screening & Assay Development
- Generates validated single-cell transcriptomic profiles for downstream assay development.
- Ensures reproducibility and standardization through rigorous cell quality control and quantitative outputs.
- Prepares high-quality biological systems for scalable compound screening and evaluation.
- Enables platform reuse across different tissues and species with protocol optimization.
Translational & Preclinical Research
- Aligns single-cell gene expression data with disease-relevant biomarkers for translational research.
- Supports continuity from discovery through preclinical validation by mapping cell-type-specific changes in health and disease.
- Informs risk-adjusted advancement decisions based on robust cellular and molecular insights.
- Provides predictive de-risking for therapeutic hypothesis testing in metabolic disorders.
Pipeline & Workflow Integration
This protocol integrates into the discovery continuum from early target validation through preclinical research, enabling high-throughput, quantitative analysis of cellular heterogeneity.
- Discovery Biology: Supports hypothesis testing and pathway clarification by resolving gene expression at the single-cell level.
- Screening: Delivers reproducible, quantitative transcriptomic outputs for assay readiness and compound evaluation.
- Analytics: Provides robust statistical measurements and clustering analyses to compare cell populations and conditions.
- Translational Research: Connects cellular transcriptomic profiles to disease-relevant biomarkers and preclinical endpoints.
- Enterprise Reuse: Offers a scalable, adaptable workflow for diverse tissues and research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes single-cell workflows with rigorous quality control and scalability.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio management.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of metabolic disease programs.
Implementation Considerations
- Requires expertise in single-cell dissociation, microfluidics, and transcriptomic analysis.
- Demands access to automated cell counters, microfluidic partitioning devices, and high-throughput sequencers.
- Necessitates cross-team standardization of quality control checkpoints and data analysis pipelines.
- Protocol optimization may be needed for different tissue types and species.
- Careful handling and rapid processing are critical to maintain cell viability and data quality.
Biopharma FAQs
Why does null hypothesis testing matter for single-cell cluster validation?
Null hypothesis testing in cluster analysis ensures that observed differences in gene expression between cell populations are statistically significant, supporting robust target validation. This reduces the risk of false positives in identifying disease-relevant cell types. Reliable statistical thresholds guide confident advancement of candidate targets.
How does independent variable isolation fit in islet dissociation and sequencing?
Isolating variables such as cell viability and dissociation quality during sample preparation ensures that downstream transcriptomic differences reflect true biological variation. This strengthens the discovery pipeline by minimizing technical artifacts. Controlled isolation supports reproducible and interpretable data for target discovery.
What do quantitative dependent variable measurements enable in single-cell RNA-seq?
Quantitative measurements of gene expression per cell enable precise mapping of cell-type-specific transcriptional profiles and identification of rare subpopulations. These outputs inform mechanistic understanding and facilitate data-driven target prioritization. High-resolution quantification supports predictive confidence in early discovery.
Why are replication requirements critical for cross-functional islet analysis?
Replication across multiple islet samples and donors ensures that findings are robust and generalizable, supporting cross-functional collaboration between discovery, translational, and biomarker teams. Consistent replication underpins portfolio-level decision making. It also enables benchmarking of protocol performance and data quality.
What statistical analysis capabilities are required before implementing single-cell clustering?
Robust statistical tools are needed to normalize gene expression, identify variable genes, and perform principal component and clustering analyses. These capabilities ensure accurate delineation of cell types and subpopulations. Proper statistical analysis is essential for actionable insights and downstream R&D integration.
Chapters in this video
0:04
Title
1:01
Human Islet Dissociation
2:30
Single Cell Suspension Quality Control and Single Cell Partitioning
4:10
Single Cell cDNA Amplification
6:19
Library Sequencing
8:11
Read Alignment and Data Analysis
9:53
Results: Dissociation, Single-cell Emulsion, cDNA Library, and Cell Types
11:09
Conclusion
